CompletedEarly Phase 1

Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention

80 participantsStarted 2007-08

Plain-language summary

The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF) cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * to be at risk of OHSS were invited to participate in the study Exclusion Criteria: * age \> 40 years

What they're measuring

risk of ovarian hyperstimulation syndrome

Timeframe: 12 days

Trial details

NCT IDNCT01530490

SponsorHospital de Cruces

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-08

View on ClinicalTrials.gov More Complications Associated With Artificial Fertilization trials